Stocks to Watch: DELL, QSFT, GSK & More

Check out which companies are making headlines after the bell Thursday:


Dell , Quest Software - Dell is the "strategic bidder" that offered to buy Quest Software for about $2.15 billion in cash, according to a Reuters report, topping an initial offer by Insight Venture Partners. (Click here for extended-hours quotes.)

GlaxoSmithKline - The FDA approved the pharmaceutical giant's Menhibrix, a combination vaccine for children. (Click here for extended-hours quote.)

Dyax - The biopharmaceutical company announced it is halting a phase 2 study of its drug to treat a rare disease that causes swelling beneath the skin after the treatment failed to show significant improvement compared with a placebo. Shares plunged in extended-hours trading. (Click here for extended-hours quote.)

DTE Energy - The company boosted its quarterly dividend by 5.5 percent to 62 cents from 58 cents. (Click here for extended-hours quote.)

YPF Sociedad Anonima - Billionaire investor Carlos Slim disclosed an 8.4-percent stake in the company. Shares surged in extended-hours trading. (Click here for extended-hours quote.)

—By CNBC’s JeeYeon Park (Follow JeeYeon on Twitter: @JeeYeonParkCNBC)

Questions? Comments? Email us at marketinsider@cnbc.com

  • Patti Domm

    Patti Domm is CNBC Executive Editor, News, responsible for news coverage of the markets and economy.

  • Bob Pisani

    A CNBC reporter since 1990, Bob Pisani covers Wall Street from the floor of the New York Stock Exchange.

  • Sharon Epperson

    CNBC's Senior Personal Finance Correspondent

  • JeeYeon Park

    JeeYeon Park is a writer for CNBC.com. Follow her on Twitter: @JeeYeonParkCNBC

  • Rick Santelli

    Rick Santelli joined CNBC Business News as an on-air editor in 1999, reporting live from the floor of the Chicago Board of Trade.

  • Peter Schacknow

    Senior Producer at CNBC's Breaking News Desk.